Smith ScholarWorks
Theses, Dissertations, and Projects
2013

Social workers in private practice and psychotropic medications
Rosy L. Metcalfe
Smith College

Follow this and additional works at: https://scholarworks.smith.edu/theses
Part of the Social and Behavioral Sciences Commons

Recommended Citation
Metcalfe, Rosy L., "Social workers in private practice and psychotropic medications" (2013). Masters
Thesis, Smith College, Northampton, MA.
https://scholarworks.smith.edu/theses/620

This Masters Thesis has been accepted for inclusion in Theses, Dissertations, and Projects by an authorized
administrator of Smith ScholarWorks. For more information, please contact scholarworks@smith.edu.

Rosy L. Metcalfe
Social Workers in Private Practice
and Psychotropic Medications

ABSTRACT
This study explored how social workers in private practice view the role of psychotropic
medications in treatment and handle psychopharmacological issues in practice. It specifically
focused on social workers’ perspectives on the helpfulness of psychotropic medications and the
nature of their communication with prescribing providers. Split treatment has become the
standard arrangement for providing both psychotherapy and psychopharmacotherapy to mental
health clients, yet there is limited research on issues that social workers encounter in split
treatment relationships and how they view them. Fifty-six independently licensed social workers
who provided psychotherapy in private practice completed a mixed method survey that asked
them to share demographic information about their practices, their perspectives on the
helpfulness of psychotropic medications and prescribing providers for their clients, and the
nature and frequency of their communication with prescribing providers. The findings indicate
that overall, social workers in private practice find psychotropic medications and prescribing
providers to be helpful for their clients, but there is a fair amount of variation depending on the
type of mental illness being treated and the type of prescribing provider in the split treatment
relationship. The findings also indicate that communication between social workers and
prescribing providers is insufficient, and is affected by a multitude of barriers that arise in split
treatment relationships.
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CHAPTER I
Introduction
The purpose of this study is to explore the relationships that private practice social
workers have with psychotropic medications when practicing psychotherapy, specifically
looking at their own perspectives on psychotropic medications in practice and the nature of their
professional relationships with prescribers of psychotropic medications. This study was
conducted with the goal of filling the Smith College School for Social Work masters thesis
requirement for the masters in social work (MSW) degree program. It is based on a mixed
method survey tool that was disseminated to participants via the internet or a mailed paper copy.
In order to have taken part in the study, participants were required to be independently licensed
clinical social workers who were providing psychotherapy in private practice to adult clients.
Much of my desire to research this topic came from my work as a first year social work
intern where I was placed on an inpatient psychiatric unit at a teaching hospital in New England
for seven months. There, it was often my responsibility to coordinate care between outpatient
therapists and prescribing providers for patients who were discharging from the unit. Many
patients did not have outpatient providers who could prescribe psychiatric medication, and it was
often very difficult to find prescribers who focused on mental health care, such as psychiatrists
and psychiatric nurse practitioners. Patients often had to be discharged with the agreement that
their primary care practitioners would monitor their responses to their psychotropic medication
regimens. Some primary care providers were comfortable with this, but others were often very
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hesitant, especially if the patients were being discharged on medications that were more
complicated to manage. I was also responsible for making sure that patients had follow up
psychotherapy services with licensed providers who were often social workers. These providers
were also often worried about their clients not having adequate help with psychotropic
medications. It seemed very rare that we could discharge psychiatric inpatients into the care of
psychotherapists and psychotropic medication providers who had consistent professional
relationships with each other. There were a few occasions where some of my patients had
outpatient psychiatrists and outpatient therapists who did not agree on how best to treat their
clients. They had been providing treatment with no discussion or real awareness of each other’s
reasoning and motives, seeming as if they were almost treating different clients. The treatment
arrangement appeared as though it could easily become iatrogenic. Some examples of what I saw
included a therapist who neglected to bring the psychiatric nurse practitioner into the loop in
order to discuss the role of medications in a client’s recent suicidal crisis; or, a psychiatrist who
was not willing to consider feedback from the clinical social worker which contradicted her
diagnosis of bipolar affective disorder and subsequent decision to place the client on lithium.
In thinking about the possiblity of becoming a clinical social worker and
psychotherapist, I wanted to find out more about how licensed clinical social workers in the
world of outpatient psychotherapy were percieving and handling dilemmas related to
psychotropic medications, since it seemed like the system of provding split-treatment for mentalhelath clients had many weaknesses. After looking into some of the current research that was
available, it became apparent to me that there were not many updated studies that looked into
into the state of the split-treatment system and relationship to clinical social workers. The goal of
the following chapter is to provide a review of the literature relevant to the roles of social
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workers as psychotherapists when psychotropic medication is part of the treatment process. It
also provides a theoretical and empirical foundation for this study. Following the literature
review chapter is the methodology on how the study was conducted. It is presented in a way so
that this study can be easily replicated or built upon in the future. Finally, the discusion chapter
reviews much of the findings, and highlights their implication for social work and mental helath
practice. It also points out other topics for future study which I uncovered through my work but
was not able to investigate through this study.
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CHAPTER II
Literature Review
Split Treatment and Professional Responsibilities:
Today, "split treatment"is one of the most predominant forms of service provided to
individuals who suffer from mental illness. It is a major reason why social workers in private
practice and prescribing provider relationships are important in the effective treatment of mental
illnesses. In split treatment, patients generally have two practitioners who are accountable for
their mental health needs. First is the psychotherapist, who is often a non-physician, which
includes social workers and psychologists. The second individual is a "pharmacotherapist" or
prescriber of psychotropic medication (Kahn, 1991).
Balon states that split treatment has both positive and negative aspects. The positive
aspects include cost-effectiveness, more time spent with clients by providers, a broader range of
talent available to clients, a greater chance for clients to have at least one provider with a similar
ethnic background, and more opportunities for providers to offer professional support to each
other. Negative aspects include the possibility for "splitting" to occur between clients and
providers, greater potential for discrepancies in communication between individuals, intervention
decisions made by one provider without considering information from the other provider,
confidentiality, legal and clinical responsibility grey areas, and the fact that collaboration time is
often not reimbursable (Balon, 2001).
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Kahn (1991) states that split treatment must be a "three-way therapeutic alliance in which
all share a common "reality" overview of the illness and the treatment plan." Kahn writes some
of the most problematic issues in split treatment arise when providers disagree on whether or not
to prescribe medication, along with transference and countertransference triangles between the
providers and patient. This implies that frequent and effective communication between all
providers and the client is necessary for split treatment to be effective
Gutheil and Simon go farther in the discussion of problems that can arise during
split treatment by recommending that providers use the "Eight Cs" of collaborative treatment in
order to safeguard clients from abandonment and other problems that can arise in split treatment
relationships. These are "Clarity, Contract, Communication, Consent, Contact, Comprehensive
view, Credentialing, and Consultation". In summary, the "Eight Cs" state that providers should
have a clear understanding of each other's responsibilities, and should focus on maintaining
regular and cooperative communication with each other. This process can be aided by having
written agreements outlining each other's responsibilities and reaching out to other providers for
consultation when necessary (2003).
Bentley, Walsh, and Farmer (2005) write that for social workers, the practice of referring
clients for medication should be taken “as seriously as they do other aspects of service delivery.”
They advise that the social worker’s responsibilities in the referral process should include
establishment and maintenance of collaboration between the social worker and prescribing
provider, providing psychoeducation on medications for clients and other supportive individuals
involved in their treatment, exploring the meaning of psychotropic medication with clients and
their supporters, helping clients to prepare for meetings with prescribing providers and then
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following up on the outcome of these meetings, and management of legal and ethical issues
related to treatment with medications.
The next two sections in this literature review discuss theories and paradigms that
could influence social workers’ perspectives and interventions related to practice with
psychotropic medications, specifically if and when they choose to refer clients for medication
consultation. One point that is argued to be universal no matter what theoretical foundation is
used is that the possible consequences of making the choice to not refer a client who might need
medication are far worse than referring one who ultimately does not need medication (King &
Anderson, 2004; Klerman, 1990; Malcom, 1986). Social workers do not have the proper training
to make the decision to prescribe a medication, but they do have responsibility of making sure
that clients have access to levels of mental health treatment beyond scope of social work
practice. All clinicians must keep this in mind when faced with the decision to refer a client for
psychotropic medications. However, this is a topic beyond the scope of this review.

Biopsychosocial and Medical Models:
Concepts pertinent to the study of the social worker's relationship with
psychopharmacology include the medical model of treating mental illness. This is the driving
force behind psychopharmacology, since it assumes that mental illness can be fixed though
biological changes. The biopsychosocial model, or BPS model, of mental illness is what frames
most clinical social worker training. A 2010 study on peoples’ perceptions of psychiatrists found
that social workers value providers who can look beyond the medical model in terms of
understanding mental illness (Bhugra, Gupta, Smyth, and Webber, 2010). Although not every
psychiatric or social work paper explicitly states and debates theory on the medical vs. the BPS
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models, they are both very important for the social worker to consider at the level of practice
because each one informs different ways of forming assessments and treating clients. In
empirical literature relating to the question of "How do social workers in private practice view
the role of psychotropics in treatment and handle psychopharmacological issues in practice?” the
significance of the medical models and BPS models are not explicitly discussed. Rather, it seems
that there is an implied understanding that these studies are supported by variations of either
model. It is important to explore the concepts and theories from both of these models, because
they are the primary foundations for psychopharmacological and social work practice. In
working to answer the research question in this study, the assumption is that social workers
responses will be informed by their views on both of these models.
Social workers who focus on using evidence based practice, or EBP, use the medical
model to inform their practice as stated here by Adams, Matto, and Lacroy (2009). “EVIDENCEBASED PRACTICE (EBP) is a term that is now widely used in social work and psychosocial
disciplines. Modeled after evidence-based medicine, a state-of-the-art approach where the focus
is on finding appropriate treatments (pharmaceutical, medical, and surgical) for a patient's
medical conditions”. EBP focused social workers may be more willing to encourage their clients
to consider psychotropic medications as an adjunct to therapy because of EBP's direct link to
evidence-based medicine, or the medical model. Addams, Matto, and Lacroy acknowledge the
usefulness of the current shift towards and EBP paradigm and social work, but they also
advocate caution in how far this is carried out. They emphasize that using evidence based
medicine to develop EBPs answers questions with a very narrow focus, with the goal of
producing “wright or wrong” answers on how to treat specific diagnoses. They warn that this
could generate too much focus on treating symptoms of specific diagnoses without looking at a
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more holistic picture of client’s environments, strengths, concerns, previous experiences, and
their overall need for services (2009).
The approach that they are advocating social workers take in this excerpt is more of BPS
approach, because they should not look at just “treating” the diagnosis, but also investigate other
factors such as those that are part of the family environment. One of the first health care
providers to capture the essence of this and name it the “biopsychosocial model” was the
physician, George Engel, which he first summed up in 1977:
To provide a basis for understanding the determinants of disease and arriving at rational
treatments and patterns of health care, a medical model must also take into account the
patient, the social context in which he lives, and the complementary system devised by
society to deal with the disruptive effects of illness, that is, the physician role and the
health care system. This requires a biopsychosocial model. (1992, p.324)
Although antiquated, this statement clearly articulates the different levels of approach that the
medical model does not take into account in treatment, and it still informs BPS practice in
clinical social work and more holistic medicine today. When working on the foundations of the
BPS model, a challenge that clinical social workers face with pharmacological issues is how
much credit to give the biological perspective versus focusing on the psychological and social
angles when assessing and helping clients. This includes the question of how much should
clinical social workers try to improve upon psychological and social factors in clients’ lives
before suggesting that they consider seeing medication prescribers.
Treatment Techniques:
Talk-therapy treatment techniques that clinical social workers use in private practice such
as Psychodynamic or Cognitive Behavioral Therapy (CBT) also can inform their relationships
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with psychopharmacology. From a historical perspective, Roose describes psychodynamic
psychotherapy as standing in opposition to the treatment of mental illness with psychotropic
medications, because its etiology was based on unconscious conflict, not neurobiological
processes. This line of separation eased as the efficacy of medication in treating schizophrenia
and some affective disorders became a reality (1998). Even though psychodynamic
psychotherapy is commonly used alongside pharmacotherapy today, its historic foundations still
inform the way that clinical social workers working from a psychodynamic perspective see their
clients' problems. As a result, they may be less apt to incorporate the topic of psychotropic
medications in dialog with their clients. Another factor is that many clinicians use a combination
of treatment techniques based on their own preferences, the needs of their clients, and their
clients’ preferences. In these situations, clinical social workers’ interventions may vary based on
the situation and the theories that they incorporate from different techniques.
CBT is a therapeutic treatment technique that has often been viewed as a compliment to
psychotropic treatment of mental illness, because they both have similar antidepressant and
anxiolytic effects. The goal of CBT is to help clients recognize and change distorted thought
patterns, which in turn has a positive affect on their emotions. Recent research is now finding
that the combining both therapies are not necessarily advantageous as opposed to CBT or
pharmacotherapy alone when treating specific anxiety disorders (Davis et al., 2006). Research on
the treatment of such disorders may even suggest that in some cases it might be most effective to
stick with only one of these treatment techniques, depending on the type of anxiety disorder a
person is struggling with. In the case of using CBT to achieve extinction of a particular response
to stress, the use of psychotropic medications to treat symptoms might prevent this from
happening. On the other hand, there is new research highlighting medications that are designed
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to enhance the effects of evidence-based psychotherapy such as CBT. These medications do not
cover up symptoms; instead they work on neurological pathways that create the distorted
thoughts that CBT also addresses (Davis et al., 2006). As a result of this history and new
research, CBT social workers could have varying approaches and views on the role of
psychotropic medications in psychotherapy, which is what the research question "How do social
workers in private practice view the role of psychotropics in treatment and handle
psychopharmacological issues in practice?” intends to explore, along with the approaches and
views of social workers using other types of treatment including psychodynamic, family systems,
eclectic, etc.
Empirical Findings on Social Workers' Perspectives:
Currently, empirically supported information on how social workers perceive the role of
psychotropic medications in the treatment of people who suffer from mental health issues is
limited. With regards to this subject, there are a few studies that are specific to working with
younger client populations. The Moses and Kirk (2006) quantitative study that was a mail survey
based on sampling from a random group of NASW social workers who worked with adolescents.
This study concluded that overall, social workers feel that psychopharmacological treatment for
adolescents is more beneficial than detrimental, although many of the respondents highlighted
common concerns with this type of treatment. The second study by Moses (2008) on adolescents
investigated the topic of social workers perspectives on psychopharmacological treatment of
adolescents with more specificity than the first, as it considered the different types of
psychotropic medications clients were prescribed, psychological factors concerning client
readiness, willingness, support for taking psychotropics, along with the social workers personal
attitudes towards the use of these medications. It illustrated that the perspectives that social
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workers have on the topic of adolescent psychopharmacology are complex, and cannot be
summarized by the “all or nothing” categories of “helpful or harmful”. It found that social
workers who are better informed about the effects of psychotropic medication tended to view it
as more helpful for their clients, resulting in higher levels of client self-esteem, self efficacy,
sense of normalcy, etc. The study also suggested that social workers differentiate between the
effects that medication has on target symptoms (such as behavior and mood) and the “meta
effects” of medication, such as hopes, fears, and the meaning ascribed to taking medication. The
study reccomended that this latter finding could be further explored by in depth-qualitative
interviewing.This suggests that if a study's questions are too limiting, it also will not be able to
effectively capture and summarize the themes that it is supposed to explore.
Content and Methods of Empirical Surveys:
A great deal of the literature studying clinicians relationships with psychopharmacology
is biased by gathering data from predominantly white, well educated clinicians who are members
of NASW, such as some of the studies Moses and Walsh. An example being Walsh's 2003 study
called “Ethical Dilemmas of Practicing Social Workers Around Psychiatric Medications”. A
reason for this is gathering data from clinicians is much less risky from an ethical standpoint than
gathering it from patients, and using the NASW for recruiting a sample simplifies the process.
The problem with this is it excludes social workers who are not members of NASW, which may
unintentionally exclude social workers with smaller financial resources since NASW's member
fees are quite significant. It is important to consider how the NASW member pool differs from
the overall population of social workers in the US, and how it could affect the data from Walsh'
studies.
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In the Walsh Study, one of the major research questions regarding the topic of
psychopharmacology was “What specific ethical dilemmas do social workers face and how
bothersome are they?” Survey categories for ethical dilemmas were generated by feedback from
focus groups at the beginning of the study. The pre-determined ethical dilemmas were listed on
the mailed surveys, and respondents were asked to list how frequently they encountered each
dilemma and numerically scale how bothersome it was. There was also an open-answer section
for respondents to describe and rate “other” ethical dilemmas that were not addressed in the
survey questionnaire.
Another mixed method study investigated how competent social workers felt within their
roles and activities concerning psychotropic medication issues by asking quantitative questions.
A qualitative section in this study also investigated how social workers thought that they could
be successful and what they desired to change regarding their practice with clients and other
providers on the subject of psychotropic medications (Bentley, Walsh, & Farmer, 2005). Some
of the topics that social workers felt most competent with include discussion of clients' feelings
and regarding medications, monitoring compliance, encouraging clients to take medication,
preparing clients to speak with physicians, making referrals to prescribers, communicating about
medication compliance to prescribers, and helping families contact physicians. Social workers
felt the least competent with assessing the severity of side effects, suggesting that physicians
change a medication, providing clients information on how medications work, facilitating
psychoeducation groups on medication, and ensuring that client's medication blood levels are
checked when needed. Some of the activities in this study looked at are more likely to be
conducted by social workers in case management roles, including helping clients fill their
pillboxes, delivering medications, and transporting clients to physician's appointments. The use
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of the term "physician" to signify prescribers is also confusing because many clients get their
medication from primary care practitioners and non-physician prescribers such as nurse
practitioners and physicians' assistants.
All of these studies do not limit the participants to only social workers in private practice
because most previous research appears to have mixed agency based social workers with private
practice social workers. In private practice, they may be more isolated from other practitioners,
specifically those who are prescribers, so they might encounter different issues or dilemmas than
the groups of respondents that all of these studies have used. So, the goal of this study is to
specifically target the experiences of this more isolated group.
Empirical Findings on What Happens in Practice Involving Split-Treatment:
There is dearth of research on what social workers are actually doing in terms of handling
issues of psychopharmacology in their day to day work, since most of the research focuses more
on their perspectives on how things are or how they would like them to be. Some information on
this topic can be found in the quantitative section of Bentley, Walsh, and Farmer study 2005,
which investigated how frequently social workers engage in activities connected to the use of
psychotropic medications by their clients in a “typical month”. The data is presented by the
percentage of respondents who specified that they engaged in specific activities “very
frequently”. Over 70% of respondents said that they frequently make referrals to physicians for
medication consultation, and discuss with clients “feelings about taking medication” and the
“desired combined effects of medication and psychosocial interventions”, but only 46% consult
with physicians very frequently regarding the effectiveness of client’s medications. A potential
problem with this study is the questions regarding frequency of engaging in activities were
subjective. Instead of asking for quantitative answers on how frequently respondents engaged in
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each activity, possible answers were subjective such as “often” or “very frequently”.
Respondents’ answers could have varied greatly depending on their own perceptions of how
frequently they engaged in the activities that this study investigated.
There are a few studies that cover this topic focusing on the more general population of
psychotherapists, some of which include social workers. The Hansen-Grant and Riba study from
1995 is an earlier study that examined communication between psychiatric resident physicians
and psychotherapists over a five-month period. Data was gathered from quantitative surveys
filled out by 13 psychiatric residents and patient charts. The surveys asked residents about the
frequency and types of communication that they had with psychotherapists. The study concluded
that communication between psychiatric residents and therapists was not adequate, due to it
being irregular, infrequent, and inconsistently documented. Being over fifteen years old and
based on a very limited and small sample, it would be very worthwhile to look again at some of
the questions that this study aimed to answer.
Another study that looks at the relationship between psychopharmacology and
psychotherapy practice is the Springer and Harris study (2010) that examined licensed Marriage
and Family Therapists' (MFTs) attitudes towards this subject and how they would act in a
hypothetical situation. This study used a randomized sample of 322 respondents who were blind
to the study's purpose. All participants were asked to read a clinical vignette, then give their
impressions on diagnosis and what direction to proceed in with treatment. The goal was to look
at which clinicians would refer the client in the vignette for medication consultation. A three part
mixed-method questionnaire was used that included open-ended questions about participants’
beliefs, demographic questions, and a Likert-scaled quantitative section that asked more specific
questions about participants’ beliefs and attitudes. Only 35.7% of the participants said that they
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would refer the client in the vignette for a psychiatric medication consultation, even though the
researchers designed the vignette to appear as though a consultation was probably indicated
based on current evidence based literature. Twenty-six percent of the clinician respondents failed
to explicitly diagnose the client in the vignette with major depression, even though it was
determined through focus groups during the design phase that the vignette clearly portrayed a
client suffering from symptoms specific to major depression. While using a vignette is a creative
way to approach clinicians' attitudes and beliefs, this study did not account for all variables that
could have affected participants' responses. One thing that the study should have explored more
is the assessment and decision-making that the respondents used before determining their
diagnostic impressions and whether or not to refer for medication, since the responses to the brief
clinical vignette did not capture this. Respondents might have followed the belief that a
preemptive diagnosis or referral could be stigmatizing without further exploration or rapport
building.
The Avena and Kalman study (2010) explored the topic of communication between
psychotherapists and psychopharmacologists. A total of 53 non-prescribing psychotherapists
were recruited through a Cornell University listserv and snowball sampling. They were mailed a
brief quantitative questionnaire that questions about respondents caseloads, work experience, and
the frequency at which they communicate with their clients' psychotropic medication prescribers.
The study questions used in this questionnaire were very specific to just communication with
prescribers, and did not leave room for respondents to elaborate on their experiences and
perspectives since they were purely quantitative. This study found that of the 434 patients on
psychotropic medication, for 22% of these cases there was no communication between therapist
and prescriber. The statistical significance of the findings from this study is unclear and not
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mentioned in the results section, so it appears that it was primarily a descriptive study. The goals
of my study go beyond this by looking for statistically significant relationships between social
worker communication and other descriptive variables.
Study Goals Based on the Literature
Ultimately, the goal of this study is to begin to build on the research of social worker's
relationships with psychopharmacology because this is an area where there is a lack of empirical
data. Since it also is an area that seems to lack a significant research base, studying this subject
might open up new avenues of discussion. Based on this review of the literature, there are no
studies that investigate the relationships between clinical social workers’ own perspectives on
medication, their related interventions in treatment, and the frequency and quality of their
communication with providers who prescribe psychotropic medications. This study aims to
investigate some of the relationships between all of these topics in the realm of split-treatment
psychotherapy practice. Since there is a general lack of empirical literature in this area, there is
also a need for this study to be more exploratory in nature, since there is a possibility many
situations that arise in treatment have not yet been discovered by current research.
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CHAPTER III
Methodology
This is a cross-sectional, mixed-method, descriptive and exploratory study that addresses
the question of "How do social workers in private practice view the role of psychotropics in
treatment and handle psychopharmacological issues in practice?” As a result, its goal is not to
investigate causality, only description and exploration of the issues within this topic are of
interest. The study is mixed-method because the survey can provide both quantifiable data, while
also allowing for responses that provided greater depth and variation within the open-ended
questions. Having more exploratory open-ended questions was further reinforced by the reality
that there is not a great deal of current research on the topic of social workers’ relationships with
psychopharmacology and previously validated assessment tools.
Sample:
Inclusion criteria required that participants were licensed to independently
practice as clinical social workers at a master’s level. They also had to provide psychotherapy
within a private practice format as opposed to working within a larger human services or mental
health agency. The last criterion was that they must work with individual clients over the age of
18. This was a nonprobability convenience sample. Since this sample was generated for a mixedmethod study and elements from the population do not have an equal chance of selection, it is
not representative of the general population. Instead, the goal was to undertake an exploration of
the experiences and perspectives of this group of respondents.
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The initial sampling frame was all clinicians on the MBHP website. The MBHP website
was selected as a starting point for recruitment in an effort to obtain a more diverse sample that
works with more economically marginalized populations, since MBHP is made up of providers
who provide mental health care for those who cannot afford private insurance. Many MBHP
providers provide services to individuals with private insurance as well. If an individual who I
contacted was interested in participating in the study, I asked for his or her email to send a link to
the internet survey, or a physical mailing address to send a paper copy of the survey. I contacted
all of the licensed clinical social workers on the MBHP website who listed working phone
numbers. The total was 222. Approximately ten percent of the MBHP providers expressed
interest in participating, so I had to expand the scope of my sampling in order to reach the goal of
50 participants. As a result, I contacted 225 New England providers through the Psychology
Today provider website were also contacted using their publicly available phone numbers and
email addresses. A snowball sampling method was also used in order to generate a larger sample.
For the snowball sample, participants who had already volunteered to help complete the survey
were asked to generate other contacts. Using Psychology Today and snowball sampling
expanded the geographic region from which the original sample was to be derived, and also
expanded the sample social workers who were not MBHP members. The disadvantage of the
sampling methods used in this study is that this sample is not representative of the general
population of social workers in private practice. The strength is that the MBHP providers who
cover underserved populations were given the opportunity to participate. This sample is mostly
restricted by geographic location within New England and individuals and associates of those
who were not MBHP or Psychology Today providers were excluded.
Data Collection:
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A paper list of participant candidates was generated during the recruitment phase
though the MBHP and Psychology Today websites and particiapnt referrals through the
snowball sampling method. This list was used to keep track of how and when each candidate was
contacted and invited to participate. This list remained secured in a locked file and was only
viewed by myself. It was destroyed after data collection was completed.
Most of the data was collected via an anonymous internet-based survey with the
SurveyMonkey platform. SurveyMonkey was selected over other internet survey platforms
because it is the preferred internet survey tool at the Smith College School for Social Work due
to the anonymity safeguards that it provides by disguising the IP addresses of participants.
Participants were also given the option of completing a paper-based survey as an alternative to
the internet survey. The paper-based survey included the same informed consent and questions as
the internet survey. It was mailed to participants with a self-addressed stamped return envelope.
A total of 12 surveys were completed by pen and paper.
Participants were instructed to not include their return addresses with completed surveys
in order to preserve anonymity. SurveyMonkey and paper-based surveys also did not ask for any
identifying information. For return addesses that were accidentaly included, I removed and
destroyed all identifying information such as names or agency names from return envelopes for
the paper-based surveys. Informed consent forms were removed from paper-based surveys and
kept in a separate location. I entered the the data from each completed paper-based survey into
SurveyMonkey. Written responses to qualitative questions were transcribed word-for-word. At
this point all of the data was stored within SurveyMonkey, therefore it was anonymous through
the use of SurveyMonkey’s anonymity safeguards. My research advisor, Jennifer Perloff was
given access to quantitative data in the form of a SurveyMonkey excel file and the qualitative
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data from open-ended questions after I removed all identifying information. Complete copies of
the IRB application and informed consent form are included in the appendix section at the end of
this report.
The main data collection instrument for this study was a survey of my own design, which
was created to gather qualitative data, quantitative data, and some demographic data on each of
the participants. Some of the survey tools covered in the literature review section of this paper
served as informal foundations for this survey tool, with this survey going into more depth
regarding the frequency and nature of provider communication. “Section A”, the demographic
section, asked participants to specify their age, sex, race, years practicing psychotherapy,
treatment modalities used, practice setting, caseload, primary issues of focus, and percent of
clients currently taking psychotropic medications. For demographic questions where it was not
feasible for me to list all possible answers, the option of “other” was provided as an answer
choice, along with a space for participants to specify what their response was. Following the
demographic data, the survey had two separate sections of questions. The first section, “section
B”, inquired about social worker’s working relationships with prescribing providers, while the
next section, “section C”, specifically addressed social workers’ perspectives on the use and
helpfulness of psychotropic medications. A complete copy of the survey instrument is included
in appendix D of this report.
Qualitative questions were all open-ended so as to give participants the change to
elaborate into some depth about their perspectives and experiences. In order to account for
possible omissions that could affect the results of qualitative data, the “Is there anything else?”
question was included at the end of sections B and C. Sections B and C each contained
qualitative questions, with a total of six for the entire survey. Quantitative questions were present
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in all sections in multiple-choice format. For quantitative questions addressing “helpfulness”,
Likert scales were used with possible responses being “strongly agree, agree, disagree, strongly
disagree, and not sure”. Multiple choice questions in section B asked participants to specify how
many of each type of prescribing provider they communicated with, the frequency of this
communication, and social workers’ perspectives on the relative helpfulness of different types
prescribing providers. Section C asked participants to specify how helpful they felt psychiatric
medications were for different diagnoses of mental illness.
The main risks of participation in this study were emotional stress as a result of
answering the survey questions and the possibility of breach of confidentiality. Some of the
survey questions asked participants do describe their beliefs and subjective experiences
regarding the provision of psychotherapy and working with other mental professionals, which
some participants may have found stressful. Participants had the option of discontinuing the
survey at any time in order to minimize this risk. To address the issue of confidentiality,
participants were not asked for identifying information on any of the actual surveys (both mailed
and internet). Participants were not provided with referral information for support services since
they were all licensed mental health professionals.
Analysis:
Once all of my data was gathered and ready for analysis, open coding was used to
categorize the qualitative data for themes that were analyzed at a greater depth. All qualitative
data was collected and recorded as written text in Excel spreadsheets. Common themes were
then analyzed using frequency distribution. When initially pulling for themes from the
qualitative data, open coding was appropriate for this study because I did not have a clear picture
of what themes I will find in the responses, so being able to create new categories for themes as I
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went along was necessary. Data was grouped in such a way that it could be linked back to its
original context in the written responses in order to allow for re-examination. Responses were
read multiple times in order to maximize quantitative data yield.
In the quantitative data section, correlation of Likert-scale responses with each other
and/or other demographic data was also used to shed light on ideas for hypotheses on how
respondents’ perspectives, behaviors, and demographics might relate. This was accomplished by
using simple descriptive statistics and Spearman correlations, by comparing grouping variables
from the demographics or Likert-scale topics with other test variables from Likert-scale topics. A
relationship was considered statistically significant if the p value was lesser than or equal to 0.05.
One example included clinicians' frequency of communication with psychiatrists and their
perspectives on the “helpfulness” of psychotropic medications with clients with serious mental
illness. Weaknesses with this type of analysis include the possibility of a sample that is too small
to generate statistically significant relationships, the subjectivity and variation of responses that
occurs with Likert scales, and the fact that the diversity of the sample will be skewed by
recruitment methods. Since my total sample is fairly small (56) and limited by snowball
sampling, generalizable quantitative correlations could not made between respondent
demographics and their responses. The goal of both the qualitative and quantitative data analysis
was to expand the knowledge base of the kinds of experiences that social workers in private
practice encounter with respect to medication issues.
My own personal bias regarding psychotropic medication could have affected the results
of this study, since it is a topic that I have some strong personal opinions about. Since I created
my own survey, it was very important for me to scrutinize my questions to avoid possible bias.
In order to account for possible omissions that could affect the results, I asked a few of my
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student peers and two clinical research professionals for feedback on my survey. Having the “Is
there anything else?” question as the last qualitative question was also designed to help to
account for possible omissions resulting from the other questions.
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CHAPTER IV
Findings
This chapter summarizes the findings from a mixed method survey (Appendix D) that
was designed to explore clinical social workers perspectives on the helpfulness of psychotropic
medications, major issues that they encounter in practice when discussing psychotropic
medications with their clients, and the nature of their communication with prescribing providers
of psychotropic medications. This first part of this chapter will present the quantitative
demographic data retrieved from the study, followed by quantitative and qualitative data from
Section A and B of the survey. Lastly, the chapter will cover correlational findings based on 14
variables created from quantitative data.
Descriptive Findings:
Respondent Demographics. There were 66 total responses to the internet and paper
based survey tools in this study, but the data from only 56 was used. 10 respondents were
excluded from the study because they did not meet exclusion criteria requirements or did not
complete any survey questions beyond the initial screening questions. Of the sample of 56
official respondents, the average age was 58.9 years, with the youngest respondent being 34
years old and the oldest being 79 years old. Fifty-eight point nine percent identified their sex as
female and 41.1% identified their sex as male, which is a diverse sample in terms of sexual
identity, considering that the majority of clinicians who were contacted during the recruitment
phase were female. The sample was not diverse in terms of racial identity, with 100% of the
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respondents identifying as white. Fifty-five of the respondents listed the number of years they
had practiced psychotherapy, with a response average of 26.4 years, the least being 4 years and
the most being 48 years. Fifty-six of the respondents specified the setting of their practice, with
14.3% in rural areas, 41.1% in suburban areas, and 44.6% in urban areas.
Table 1
Demographics of the Respondents
Age

Sexual Identity

Average

59.8 years

Minimum

34.0 years

Maximum

79.0 years

Female

58.9%

Male

41.1%

Racial Identity

White

100.0%

Setting of Practice

Rural

14.3%

Suburban

41.1%

Urban

44.6%

Years Practicing
Psychotherapy

Average

26.4 years

Minimum

4.0 years

Maximum

48.0 years

The treatment techniques used by respondents are listed below on Table 2. Out if the 56
respondents, they most frequently listed cognitive behavioral therapy (89.3%), psychodynamic
(69.6%), and then eclectic (55.4%) as treatment techniques used in practice. In addition to the
three most frequently used techniques, respondents specified quite a variety of other techniques
that they use in practice, including coaching (25.%), dialectical behavior therapy (26.8%), eye
movement desensitization and reprocessing (26.8%), family systems (14.8%), humanistic
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(35.7%), mindfulness based cognitive therapy (46.4%) and psychoanalytic (19.9%). Treatment
techniques that were specified by less than 10% of the respondents are not included in the results
on Table 2. In this section, most respondents listed three or more techniques, suggesting that
most of the respondents were “eclectic” to some extent.
Table 2
Treatment Techniques of the Respondents
Treatment Technique

Percent of respondents who use technique
(n=56)

Coaching

25.0%

Cognitive Behavioral Therapy (CBT)

89.3%

Dialectical Behavior Therapy (DBT)

26.8%

Eye Movement Desensitization and

26.8%

Reprocessing (EMDR)
Eclectic

55.4%

Family Systems

14.8%

Humanistic

35.7%

Mindfulness Based Cognitive Therapy

46.4%

(MBCT)
Psychoanalytic

17.9%

Psychodynamic

69.6%

Looking at caseload demographics listed below on Table 3, Respondents had an average
caseload size of 42 clients, with the smallest caseload being 6 clients and the largest caseload
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being 150 clients. Forty-seven respondents listed the three most prominent issues of focus with
their clients. Of these 47 respondents, 89.4% reported that depression was a major issue of focus
in treatment with clients, followed by anxiety at 74.5% and relationships at 47.7%. Only one
respondent (2.1%) listed psychosis as a major issue of focus, this being the least prominent issue
among the respondents. There was a fair amount of variation within the question that addressed
percentage of caseload taking psychotropic medications. The majority of respondents (50.9%)
stated that approximately 26%-50% of their caseload is on psychotropic medications. This was
followed by 36.4% of respondents stated that 51%-75% of the caseload is on medication, 7.3%
stated that 76%-100% of their caseload is on medication, and the least number of respondents
(5.5%) stated that less than 25% of their caseload is on medication. Other issues that were listed
by less than 10% of respondents are aging, disability, grieving, personality disorders, psychosis,
relationships, sexual/gender identity, spirituality and “other”.
Table 3
Caseload Demographics
Number of psychotherapy clients

Average

42.33

in caseload n= 54

Major issues of focus in caseload

Minimum

6.00

Maximum

150.00

Addiction/Substance Abuse

(11) 23.4%

Aging

(2) 4.3%

Anxiety

(35) 74.5%

n=47
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Percent of caseload taking

Depression

(42) 89.4%

Disability

(1) 2.1%

Grieving

(3) 6.4%

Personality Disorders

(3) 6.4%

Psychosis

(1) 2.1%

Relationships

(22) 46.7%

Sexual/Gender Identity

(2) 4.3%

Spirituality

(2) 4.3%

Trauma

(16) 34.0%

Other

(4) 8.5%

Less than 25%

(3) 5.5%

26%-50%

(28) 50.9%

51%-75%

(20) 36.4%

76%-100%

(4) 7.3%

psychotropic medications n=53

Main descriptive findings. The descriptive findings came from section A and section B
of the survey, which addressed the respondents working relationships with prescribing providers
and then their own perspectives regarding psychotropic medications, respectively.
Provider communication: Quantitative findings. The quantitative data on working with
providers of psychotropic medications is listed below in Table 4. For the survey question that
asked participants to specify the “helpfulness” of different types of providers, 68.6% of
respondents specified that they agreed that psychiatrists are helpful, and 64.7 % specified the
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same with regard to primary care doctors. Only 3.9% of respondents disagreed that psychiatrists
are helpful, whereas 11.8% disagreed or strongly disagreed with the helpfulness of primary care
doctors. For the category of psychiatric nurse practitioners and psychiatric physician’s assistants,
the majority of respondents (48.8%) specified that they strongly agreed that these types of
providers are helpful, while a total of 6% either disagreed or strongly disagreed. For primary care
nurse practitioners and physician’s assistants, the majority of respondents (42.9%) specified that
they were not sure of the helpfulness of these types of providers, 47.0% agreed or strongly
agreed that they are helpful, and 11.9% disagreed or strongly disagreed that they are helpful.
These results are based on the types of practitioners that the respondents worked with in practice,
so the sample size varied between each of these statistics.
The second section of Table 4 shows the results from respondents who communicate with
the corresponding prescribing providers at least once a month. These results give a different
picture from the above results, showing that psychiatric nurse practitioners physicians assistants
are rated more favorably than the other types of providers, with 12 out of 21 respondents (57.1%)
selecting strongly agree for helpfulness in this category. For the category of primary care nurse
practitioners and physicians, the majority of respondents (7 or 53.9%) listed that they disagree
with the helpfulness of these providers. The majority of responses did not change for
psychiatrists and primary care doctors, since 64.7% of respondents for each type of provider
stated that they agree that they are helpful.
Table 4
Working with Providers of Psychotropic Medications- Helpfulness
Helpfulness of
providers
regarding
psychotropic
medications

Type of
provider

Strongly
agree

Agree
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Disagree

Strongly
disagree

Not sure

Psychiatrists (13)
25.5%
n=51

(35)
68.6%

(2) 3.9%

(0) 0.0%

(1) 2.0%

Primary
Care
Doctors
n=51

(33)
64.7%

(3) 5.9%

(3) 5.9%

(3) 5.9%

(18)
36.0%

(2) 4.0%

(1) 2.0%

(5) 10.0%

(15)
37.5%

(3) 7.1%

(2) 4.8%

(18)
42.9%

Agree

Disagree

Strongly
disagree

Not sure

(11)
64.7%

(0) 0.0%

(0) 0.0%

(0) 0.0%

(11)
64.7%

(0) 0.0%

(0) 0.0%

(1) 5.9%

(8) 38.1%

(1) 4.8%

(0) 0.0%

(0) 0.0%

(9) 17.6%

Psychiatric
(24)
Nurse
48.0%
Practitioners
or
Psychiatric
Physicians
Assistants
(psychiatric)
n=50
Nurse
(4) 9.5%
Practitioners
or
Physicians
Assistants
(primary
care) n=42
Helpfulness of Type of
providers when provider
respondents
communicate
with them
greater than or
equal to 1x per
month

Strongly
agree

Psychiatrists (6) 35.3%
n=17
Primary
Care
Doctors
n=17

(5) 29.4%

Psychiatric
(12)
Nurse
57.1%
Practitioners
or

30

Psychiatric
Physicians
Assistants
(psychiatric)
n=21
Nurse
(3) 23.1%
Practitioners
or
Physicians
Assistants
(primary
care) n=13

(3) 23.1%

(7) 53.9%

(0) 0.0%

(0) 0.0%

Table 5 lists findings from questions that addressed the frequency of respondents’
communication with prescribing providers. When looking at the frequency of communication
with specific providers, the majority of respondents specified that they communicate less than
once a month with each type of prescribing provider, ranging from 40%-60%. Within all of the
different prescribing provider categories, the lowest number of respondents specified that they
communicate more than once a week (only one respondent per category, 1.9%-2.9%). The last
two sections of this table look at communication frequency depending on the “severity” of
mental illness. The majority of clinicians specified that they communicate on average of one
time every three months with prescribing providers of clients who have “mild to moderate
mental illness” (37.7%) and “more serious mental illness” (44.9%). In general, respondents
tended to communicate more frequently regarding clients with more serious mental illness
compared to communication regarding clients with mild to moderate forms of mental illness.
Table 5
Working with Providers of Psychotropic Medications- Frequency of Communication
Frequency of
communication
with different
types of

More than
once a
week

Once a
week
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Once a
month

Less than
once a
month

Not at all

providers
Psychiatrists 1.9% (1)

7.7% (4))

25.0% (13) 55.8%
(29)

9.6% (5)

2.0% (1)

6.0% (3)

18.0% (9)

60.0%
(30)

14.0% (7)

Psychiatric
2.0% (1)
Nurse
Practitioners
or
Psychiatric
Physicians
Assistants
(psychiatric)

6.0% (3)

34.0% (17) 40.0%
(20)

18.0% (9)

2.9% (1)

2.9% (1)

34.3%
(12)

n=52
Primary
Care
Doctors
n=50

n=50
Nurse
2.9% (1)
Practitioners
or
Physicians
Assistants
(primary
care) n=35

57.1%
(20)

Table 6
Working with Providers of Psychotropic Medications- Frequency of Communication
Average frequency of
communication with prescribing
providers for clients with mild to
moderate mental illness n=51

Average frequency of
communication with prescribing
providers for clients with serious
mental illness n=52

More than 1x per week

(0) 0.0%

1x per week

(1) 2.0%

1x per month

(8) 15.7%

1x every three months

(19) 37.7%

1x a year or less

(23) 45.1%

More than 1x per week

(0) 0.0%

1x per week

(4) 8.2%
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1x per month

(12) 24.5%

1x every three months

(22) 44.9%

1x a year or less

(11) 22.5%

Provider communication: Qualitative findings.
Provider inaccessibility. In the open response questions of the survey Section A, the most
common issue was that prescribing providers are not accessible for communication about cases,
which 29 out of 56 or 51.7% of the respondents wrote about. This may include a lack of regular
responses to voicemail messages, or statements that prescribing providers are “too busy”. A
typical response that came from one of the respondents regarding this issue is that “prescribers
rarely contact me or respond to written requests for information”. Another respondent stated,
“The most common issue in dealing with a client's prescriber is the ability to actually talk to
them. Coordinating care with a PCP who is hard to get a hold of, is screened by a nurse, and is
often (meeting) with a patient like I am.” This response also touches on second most common
issue that respondents wrote about, which is that it is difficult to find time to communicate with
prescribing providers. This was often due to scheduling conflicts since providers cannot
communicate with each other when meeting with clients. The theme of “not having enough
time” was present 11 out of 56 or 19.6% of the responses.
Four respondents wrote about the supply of prescribing providers not being adequate,
specifically providers who focus on psychiatric medications such as psychiatrists and psychiatric
nurse practitioners. A comment that illustrates this from a social worker describing a group of
approximately 10-15 clients from her caseload taking psychotropic medications; “Only one of
my patients sees a psychiatrist for meds. There are hardly any in this area and those that are do
not want to simply prescribe.”
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Conflicting views. Eight of the respondents (14.3%) described generally having
conflicting views with the types of treatment provided by prescribers. Actual respondent
statements pertaining to this theme include “I would like to see the medical profession take more
of an interest in therapy which does not use psychotropics”, “On a number of occasions, there
have been problems with lack of responsiveness to the acuity of situations regarding suicidal
ideation.” and “(I) Sometimes feel that psychiatric providers do not explain enough to clients or
listen to clients' complaints with respect to the meds they are on.” Respondents also wrote about
not agreeing about the types of medication prescribed to their clients. Three respondents wrote
specifically about the issue that prescribing providers are too focused on formulating clients’
cases using biological perspectives and often disregard the psychological and social factors
contributing to clients’ mental illnesses, such as “ignorance of intrapersonal and interpersonal
issues of client”. The theme of polypharmacy or being prescribed too much of certain types of
medication was mentioned by two respondents.
Relationships with specific types of prescribing providers. Two of the respondents
reported that psychiatric nurse practitioners were particularly helpful. One even stated that that
they are “Godsend”. Another respondent wrote about relationships with ObstetricianGynecologists, describing their role in prescribing psychotropic medications as helpful; “I
receive many referrals from Ob-Gyns v. PCPs. The Ob-Gyns tend to be more tuned in to their
patients; also, the nature of the reasons for patients' visits to Ob-Gyns is often emotionally
charged (pregnancy, miscarriage, menopause, infertility, disease, etc.), so those doctors end up
doing a lot of prescribing for mild to moderate conditions, esp. depression, anxiety, post-partum,
etc.”
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Adequacy of prescribing providers. Five respondents stated that prescribing providers
who are not psychiatrists or who do not specialize in psychiatric medicine do not have adequate
knowledge or experience to prescribe psychotropic medications, including one respondent that
made this statement regarding primary care practitioners; “some of whom have little
understanding of the benefits of individual antidepressants, meaning it is not unusual to see the
patient prescribed "the wrong" or less effective med, or start patients at full doses when titration
up would limit side effects that are often temporary. Intense side effects in beginning equals noncompliance and fear of meds.” Two respondents wrote that they are “uncertain” of whether or
not their clients’ prescribing providers perform adequately.
Other issues that come up when working with prescribing providers. In section A of this
survey, six (10.7%) of the respondents reported that they feel like their input is not respected
and/or valued by prescribing providers. The same number of respondents emphasized that
teamwork is important in order to provide the best care for clients. Two respondents mentioned
having general issues with continuity of care, while two other respondents emphasized that
adequate communication does occur when a client is in crisis. When having collaborative
discussions about the efficacy of medication, two respondents stated that the general inefficacy
of medication is a common theme. Four respondents mentioned that finding adequate
medications for clients with substance abuse issues is something that they frequently have to
troubleshoot with prescribing providers.
Work with clients and psychotropics: Quantitative findings. The quantitative question
from the survey Section B on social workers views of psychotropic medications asked clinicians
to specify their level of agreement with the helpfulness of psychotropic medications depending
on the type of mental illness symptoms that clients struggle with. Overall, respondents tended to
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agree or strongly agree that psychotropic medications are helpful for each of the symptoms. For
mild to moderate anxiety, 11.3% strongly agree and 62.3% agree with the helpfulness of
psychotropic medications. Nine point four percent disagree and 3.8% strongly disagree with the
helpfulness of medications, while 13.2% said they were “not sure”. For severe anxiety, 94.3%
either agree or strongly agree with the helpfulness of medications. For mild to moderate
depression 75.5% agree or strongly agree with the helpfulness of psychotropic medications, but
94.3% either agree or strongly agree when clients struggle with severe depression. For mood
instability, 86.8 of respondents agreed or strongly agree, 3.8% strongly disagree, and 9.4% are
not sure with the helpfulness of psychotropic medications. Lastly, for psychotic symptoms
82.7% of respondents agree or strongly agree with the helpfulness of medications and 13.5% are
not sure.
Table 7
Social Workers’ Perspectives on Psychotropic Medications
Psychotropic Strongly
medications
agree
are helpful for
clients who
struggle
with…

Agree

Disagree

Strongly
disagree

Not sure

Mild to
moderate
anxiety n=53

(6) 11.3%

(33) 62.3%

(5) 9.4%

(2) 3.8%

(7) 13.2%

Severe
anxiety n=53

(27) 50.9%

(23) 43.4%

(1) 1.9%

(1) 1.9%

(1) 1.9%

Mild to
moderate
depression
n=53

(10) 18.9%

(30) 56.6%

(6) 11.3%

(1) 1.9%

(6) 11.3%

Severe
depression
n=53

(31) 58.5%

(19) 35.8%

(2) 3.8%

(1) 1.9%

(0) 0.0%

Mood

(22) 41.5%

(24) 45.3%

(0) 0.0%

(2) 3.8%

(5) 9.4%
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instability
n=53
Psychotic
symptoms
n=52

(30) 57.7%

(13) 25.0%

(1) 1.9%

(1) 1.9%

(7) 13.5%

Work with clients and psychotropics: Qualitative findings.
Side effects. The issue that respondents mentioned the most frequently when writing
about work with clients is the topic of side effects caused by psychotropic medications. Thirty of
the fifty-six respondents (53.5%) mentioned side effects being problematic at some point within
the open-ended responses of Section B. Some specific side effects that were mentioned include
“fogginess”, “weight gain”, “dry mouth”, inability to cry”, and reduction of “sexual
functioning”. Within many of these responses, it was noted that side effects contribute to clients’
fears of starting and/or staying on medications, or complying with medication regimens.
Fears and stigma. The next most frequently reported issues are regarding clients’ fears of
being on medication. Fourteen respondents (25.0%) wrote that general “fears” of being on
medication are an issue in treatment. The same number of respondents mentioned that dealing
with emotional and social stigma or processing the fear of emotional and or social stigma is
problematic for clients who are either on medication or considering going on it, respectively. An
good example from a respondent regarding this issue is, “The stigma attached to taking these
medications is often internalized by clients who then tend to see their need for the medicine as an
indication of weakness or defect.” Two respondents also reported that clients’ negative past
experiences with psychotropic medications add to their fears of trying them again.
The need for psychoeducation. Providing psychoeducation, helping clients who are
misinformed and teaching clients how to advocate for themselves when discussing psychotropic
medications in therapy were three different themes present in the survey responses. Six
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respondents (10.7%) stated that psychoeducation about psychotropic medication was an
important part of their work, which was often about helping clients to understand the positive
and negative aspects of medications. Four respondents stated that their clients are often
misinformed about medication, such as having the “incorrect information about course of
treatment and side effects.” None of the respondents were specific about the sources of
misinformation. Another related topic that five respondents wrote about was that many clients
place expectations that are too high on their medication, such as wanting it to act quickly or
eliminate all negative feelings. Lastly, seven respondents (12.5%) wrote about the importance of
clients knowing how to be advocates for themselves when meeting with prescribing providers
about psychotropic medications. One provider wrote about this regarding the issue of changes to
the medication regimen, “People need to learn that they have to advocate for themselves and
know that they must step down carefully when coming off meds. If a new provider wants to
abruptly take them off a medication, the client must advocate for him- or herself and not just
allow an abrupt change to be made.”
Changing medications and dosages. Change in the medication regimen was another
frequently mentioned issue in this section of the survey, specifically about how many clients
struggle with their medication types and dosages being changed. Six (10.7%) the of respondents
stated that this was an issue that their clients frequently bring up, especially because there are
often multiple trials before many clients are on the best medication regimen.
Building rapport. One respondent emphasized special consideration that is necessary
when working with clients who struggle with more severe forms of mental illness, “Ironically, it
is often the most ill patients that are most opposed to medication. It takes patience and building a
rapport along with informing them about the increase in control of their thought and feelings that
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will likely come from taking the medications”. He emphasizes the need to build trust in order to
help clients who are very resistant to taking medication as a result of their fragile mental states.
Issues with the prescribing provider. Six respondents (10.7%) mentioned that they and
their clients struggle with being satisfied by and/or trusting the collaborating prescribing
providers. Some of the specific issues mentioned related to this topic include “ Being diagnosed
without a comprehensive and collaborative assessment”, “Short sessions with prescribers leave
clients feeling unheard”, “resistance of the MD to modify or change the med at the appropriate
time”, and “Failure of the prescriber to be invested in the client’s real world struggles.”
Professional boundaries. When some of the respondents encounter situations where they
are questioning the prescribing provider’s actions, one of the common dilemmas that they
mentioned was overstepping the professional boundaries of their roles as social workerpsychotherapists. A total of nine (16.1%) of the respondents mentioned overstepping
professional boundaries as an issue that they struggle with in practice. In one case, a respondent
stated “Masters level clinicians can't legally recommend medications, so a fine line is often
walked when a patient is not on an appropriate medication, or is over-medicated. The fine line is
how not to anger prescribers (most often primary care docs) and still get the point across.”
Another statement that shows a more guarded perspective is, “I am very cautious about
discussing meds with patients. I am a LICSW and, as such, I feel that more than a suggestion of
referral/med check is outside my sphere of professional competence.”
The need for more holistic perspectives and approaches. Seven respondents (12.5%)
reported that their clients focus too much on the biological aspects of their treatment, specifically
medications. As a result of this, they do not give enough credit to improvements that they have
made as a result of hard work in psychotherapy. Or, they may come to psychotherapy as a
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formality when they really feel like medication is the only thing that is helping or will help them.
Two respondents emphasized the need for more holistic types of treatment that incorporate
interventions that are not traditionally a part of psychotherapy. Possibilities include incorporating
“meditation”, “breathing techniques”, “nutrition”, and “exercise”.
Other barriers to pharmacotherapy. Two other major barriers to pharmacotherapy that
respondents pointed out included clients’ struggles to be compliant with their medication
regimens and monetary issues associated with psychotropic medication. Compliance issues that
were highlighted by five respondents include, coming off medications (against medical advice)
as a result of “a desire for more autonomy”, not “taking meds as prescribed” and struggling with
“abstinence from alcohol and other drugs”. Three respondents mentioned that money was an
issue, stating that the additional cost of medications to clients and lack of therapist
reimbursement for time spent collaborating with prescribing providers prevent clients from
getting the best treatment. Two of the respondents reported that health insurance company
policies cause some of these issues.
Correlative findings: Fourteen variables were analyzed for statistically significant relationships
using the Spearman’s rank correlation coefficient. The variables are: caseload; years practicing
psychotherapy; therapy count (total number of therapeutic techniques a respondent uses); percent
of caseload on medication; frequency of communication with psychiatrists; frequency of
communication with primary care physicians; frequency of communication with psychiatric
nurse practitioners and physicians assistants; frequency of communication with primary care
nurse practitioners and physicians assistants; frequency of communication with prescribing
providers of clients with mild to moderate mental illness; frequency of communication with
prescribing providers of clients with serious mental illness; helpfulness of psychiatrists;
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helpfulness of primary care doctors; helpfulness of psychiatric nurse practitioners and physicians
assistants; and helpfulness of primary care nurse practitioners and physicians assistants. These
correlation figures can be found in Table 7.
Looking at the caseload variable, one statistically significant weak correlation was found
in relation to respondents’ frequency of communication with prescribing providers of clients
with serious mental illnesses. This was a negative correlation of about -0.33, so higher caseload
numbers corresponded with lower communication frequencies. There were two statistically
significant correlations with the age variable, both of which were also negative. These showed
relationships between the respondent’s age and their perception of how helpful psychiatrists or
psychiatric nurse practitioners and physician’s assistants are to their clients, with correlations of 0.37 and -0.32, respectively. This means that older respondent age corresponded with
perceptions of psychiatrists and psychiatric nurse practitioners/physicians assistants being less
helpful. For the percentage of respondent caseload on medications variable, negative statistically
significant correlations were found between this variable and helpfulness of psychiatric nurse
practitioners/physicians assistants along with communication frequency with primary care nurse
practitioners /physicians assistants. The correlations for these were Rho= -0.32 and Rho= -0.39,
respectively.
Statistically significant positive correlations were found between all of the psychiatrist,
primary care doctor, and psychiatric nurse practitioner communication frequency variables. The
strongest correlation was between psychiatrist and psychiatric nurse practitioner/physicians
assistant communication frequency (Rho=0.59), followed by psychiatrist and primary care doctor
communication frequency (Rho=0.46), and primary care doctor and psychiatric nurse
practitioner/physicians assistant communication frequency (Rho=0.36). There was no
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statistically significant correlation between primary care nurse practitioner/physicians and
psychiatrist communication frequency. But, there were significant correlations between primary
care nurse practitioner/physicians assistant and primary care doctor communication frequency
along with primary care nurse practitioner/physicians assistant and psychiatric nurse
practitioner/physician assistant communication frequency. Correlation values for these were
Rho=0.49 and Rho=0.61, respectively.
Respondent communication frequency with prescribing providers of clients with mild to
moderate mental illness and serious mental illness showed significant positive correlation with
respondent communication frequency with psychiatrists, primary care doctors, and psychiatric
nurse practitioners. There was no statistically significant correlation between these two variables
and primary care nurse practitioner/physicians assistant communication frequency.
Table 8
Correlative Findings
*Bold type
indicates
statistical
significance
p > or = .05

Caseload

Communication
frequency
(ComFreq):
Psychiatrists

Rho=
-0.22247
p=0.1205
n=50
Rho=

ComFreq:
Primary care
doctors
ComFreq:
Psychiatric nurse
practitioners and
physicians
assistants
ComFreq:
Primary care
nurse
practitioners and
physicians
assistants
ComFreq: Clients

Years
practicing
psychotherapy

Percent of
caseload
on
medication

ComFreq:
Psychiatrists

ComFreq:
Primary
care
doctors

Rho=

Rho=

Rho=

ComFreq:
Psychiatric
nurse
practitioners
and
physicians
assistants
Rho=

-0.13169
p=0.3570

-0.01652
p=0.9084

0.46199
p=<.0001

0.59398
p=<.0001

0.14887
p=0.3934

n=51
Rho=

n=51
Rho=

n=49
Rho=

n=35
Rho=

-0.15255
p=0.3006

-0.02142
p=0.8839

-0.13491
p=0.3554

0.46199
p=0.0008

n=50
Rho=0.35913
p=0.0132
n=47

n=48
Rho=

n=49
Rho=

n=49
Rho=

n=49
Rho=

Rho=

-0.26102

-0.00319

p=0.0731
n=48

p=0.9826
n=49

-0.21169
p=0.1442

0.59398
p=<.0001

0.35913
p=0.0132

n=49

n=50

n=47

0.49038
p=0.0032

n=34
Rho=
0.60781
p=0.0001
n=35

Rho=

Rho=

Rho=

Rho=

Rho=

Rho=

-0.08803
p=0.6151

0.14045
p= 0.4282

-0.38839
p=0.0232

0.14887
p=0.3934

0.49038
p=0.0032

0.60781
p= 0.0001

n=35

n=34

n=34

n=35

n=34

n=35

Rho=

Rho=

Rho=

Rho=

Rho=

Rho=
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ComFreq:
Primary
care nurse
practitioners
and
physicians
assistants
Rho=

Rho=

with mildmoderate mental
illness
ComFreq: Clients
with serious
mental illness
Helpfulness of
(Help):
psychiatrists
Help: Primary
care doctors

Help: Psychiatric
nurse
practitioners and
physicians
assistants
Help: Primary
care nurse
practitioners and
physicians
assistants

p=0.0377
n=50
Rho=

-0.29471

0.06061
p=0.6759

-0.03202
p=0.8253

0.59928
p=<.0001

0.34534
p=0.0187

0.30305
p=0.0384

-0.03014
p=0.8656

n=50
Rho=

n=50
Rho=

n=48
Rho=

n=46
Rho=

n=47
Rho=

n=34
Rho=

-0.32788
p=0.0229

0.00563
p=0.9697

-0.07858

0.57327
p=<.0001

0.35830
p=0.0157

0.32700
p=0.0265

0.03458
p=0.8485

n=48
Rho=

n=48
Rho=

n=47
Rho=

n=45
Rho=

n=46
Rho=

n=33
Rho=

0.20285
p=0.1621

-0.13776
p=0.3613

-0.08473

-0.00695
p=0.9689

n=49
Rho=

n=46
Rho=

p=0.5955
n=48
Rho=

-0.18437

-0.36944

-0.04608

p=0.1999
n=50
Rho=

p=0.0083
n=50
Rho=

p=0.7507
n=50
Rho=

-0.11095
p=0.4430

-0.11630
p=0.4212

-0.11243
p=0.4370

0.16946
p=0.2495

0.43399
p=0.0026

n=50
Rho=

n=50
Rho=

n=50
Rho=

n=48
Rho=

n=46
Rho=

-0.01235

-0.32449

p=0.9329
n=49

p=0.0229
n=49

-0.11243
p=0.0491

0.00108
p=0.9942

n=49

n=48

0.39118
p=0.0079
n=45

p=0.5712
n=47
Rho=
0.16411

p=0.2758
n=46
Rho=

n=34
Rho=
0.24487
p=0.1628

n=34
Rho=

0.33513
p=0.0213

0.54790
p=0.0008

n=47

n=34

Rho=

Rho=

Rho=

Rho=

Rho=

Rho=

Rho=

0.12485
p=0.4367

0.03539
p=0.8261

0.09491
p=0.5550

-0.20711
p=0.1997

0.07132
p=0.6705

0.01516
p=0.9270

0.65244
p=<.0001

n=41

n=41

n=41

n=40

n=38

n=39

n=32
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CHAPTER V
Discussion
This study explored the perspectives and experiences regarding psychopharmacological
issues of social workers working as private practice psychotherapists. It specifically focused on
their own perspectives on the helpfulness of medications for their clients and the nature of their
professional relationships with prescribing providers. It used a mixed-method survey comprised
of multiple choice and open ended questions (Appendix D) that asked participant social workers
to describe their own perspectives on the helpfulness of psychotropic medications, issues that
arise when discussing psychotropic medications with their clients, issues that arise when working
with prescribers of psychotropic medications in split treatment, and the frequency of their
communication with prescribing providers.
The results from this study suggest a few important possibilities. First is that most private
practice social workers believe that psychotropic medication is helpful, with the degree of
helpfulness varying depending on the nature of the client’s mental illness. Second, social
workers observe that their clients struggle with a multitude of conflicts affecting their
willingness to be treated with psychotropic medications. Third, social workers in private practice
find that communication difficulty between prescribing providers frequently has a negative
impact on treatment. This includes not being able to communicate frequently enough with
prescribing providers, not agreeing with prescribing provider’s treatment strategies, and not
feeling respected by prescribing providers.
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Social Workers Working with Prescribing Providers
Communication frequency. Kahn (1991) emphasizes that an effective split treatment
relationship must have productive collaboration and communication between all members. In
this study, members consist of the client, the social worker, and the prescribing provider. Despite
the importance of effective communication, the results from this study suggest that the nature of
communication is not adequate. Both the Hansen-Grant and Riba (1995) and Avena and Kalman
(2010) studies investigated the frequency of psychotherapists’ communication with prescribing
providers, and both concluded that the communication between providers was not frequent
enough for adequate treatment, with Avena and Kalman finding that 22% of their respondents
did not communicate with prescribing providers at all. In the Bentley, Walsh and Farmer 2005
study, 46% of the respondents listed that they communicate with prescribing physicians “very
frequently”. Since “very frequently” is a subjective measure of frequency, it is hard to assess. My
study also suggests that provider communication is not frequent enough. Forty-five point one
percent of respondents stated that when treating clients with mild to moderate mental illness,
they communicate with prescribing providers once a year or less. When treating clients with
serious mental illness, the majority of respondents (44.9%) stated that they communicate with
prescribing providers every three months on average, and 22.5% stated that they communicate
with prescribing providers once a year or less.
Some respondents elucidated possible barriers to more frequent communication in the
open-ended response sections of the survey. The most frequently mentioned issue was that
prescribing providers are hard to reach. Reasons for this include that they have busy schedules
and are not able to regularly follow up on phone calls and written requests to share information.
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Another possible barrier to communication frequency is the fact that many of the respondents
stated that that their own schedules were too busy in order to take time out of the workday to
contact other providers. One respondent mentioned the lack of reimbursement for time spent
outside of psychotherapy sessions is an issue, which could deter social workers from initiating
more frequent communication from prescribing providers.
Another possible cause of infrequent and ineffective communication may be a lack of
interest in social workers’ input on the part of prescribing providers. A significant number of
respondents (10.7%) felt like their input was not valued by prescribing providers, which might
cause them to put less effort into reaching out. If a significant number of prescribing providers
do not value input as these respondents have experienced, the prescribing providers may also be
much less likely to communicate frequently with social workers. Disagreement over how to treat
clients could also add to this dynamic if it results in shutdown of communication. This is also
important to consider because 14.3% of respondents in this study mentioned that disagreement
with prescribing providers is a significant issue in practice.
Statistically significant communication frequency correlations. Another significant
finding related to the issue of communication frequency is that there was a weak negative
correlation between social workers’ caseload size and their communication frequency with
prescribing providers of clients with serious mental illness. This means that social workers with
larger caseload sizes tended to communicate less with prescribing providers regarding clients
with serious mental illness. Although this is a weak correlation within a relatively small sample
size, the implication of this is very important because it could mean that when social workers
have large caseloads, the neediest clients are getting less help and support compared to clients
with more mild forms of mental illness.
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Positive correlations were found between almost all of the provider-specific
communication frequency variables, except for communication frequency with psychiatrists and
primary care nurse practitioners/physicians assistants. The statistical significance of the
relationship between these two variables was probably affected by the very small sample of
respondents who communicate regularly with primary care nurse practitioners and physicians
assistants. Given a larger sample, it is possible that a statistically significant relationship may
have been found. The trend of significant positive correlations between all of these variables
ranges from correlations of Rho=0.36 to Rho=0.61. Explaining the reasons behind the
differences in these variables is beyond the scope of this study, but it appears that if a social
worker communicated frequently with one type of prescribing provider, it is likely that she
communicated frequently with other providers as well.
Prescribing provider helpfulness. Social workers perceptions of the “helpfulness” of
different types of prescribing providers was another variable that this study investigated in order
to evaluate the adequacy of split treatment relationships. In the case of respondents who
communicated with prescribing providers at least once a month, 57.1% of those who worked
with psychiatric nurse practitioners and physicians assistants stated that they “strongly agreed”
that these types of providers were helpful and supportive to clients, whereas the majority of
respondents working with psychiatrists and primary care doctors stated that they “agreed” with
the helpfulness of these providers (64.7% in both cases). In the qualitative response section of
the study, two respondents also wrote that they find psychiatric nurse practitioners to be
particularly helpful. Primary care nurse practitioners and physicians assistants were perceived to
be the least helpful, with the majority of respondents (53.9%) stating that they “disagree” that
these types of providers are helpful. To understand the exact reasons behind these findings would
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require more exploration, but possible reasons for the non-physician psychiatric providers being
more “helpful” could be a result of their training, which might teach them to look at client
problems similar to the way that social workers are trained. Since these providers are nonphysicians, social workers may view them more as equals and therefore they might seem more
approachable. Clients may also view them as more approachable for this reason.
Statistically significant helpfulness correlations. There were weak negative correlations found
between respondent age and the perception of helpfulness regarding psychiatrists and psychiatric
nurse practitioners and physicians’ assistants, showing that younger participants tended to have
more positive views of these prescribing practitioners helpfulness and supportiveness of clients.
Determining the possible causes of this phenomena is beyond the scope of this study, but it is
still significant if it is a phenomena that occurs on a more widespread level. It would be worth
looking into factors that might influence this, including differences in educational background,
culture, and attitude that are dependent on the historical timeframes that social workers have
practiced in.
The sample for each of these categories is small since a large group from the overall
study sample size specified that they communicated with these types of providers less than once
a month. But, the differences are significant enough that the topic of other providers’
“helpfulness” would be worth exploring in greater depth to see if this trend is more widespread,
and possibly exploring reasons as to why the non-physician psychiatric prescribing providers
might be the most helpful in split treatment relationships. Since these questions regarding
provider helpfulness are quantitative but subjectively interpreted, they do not address how the
respondents perceive the meaning of these concepts. Further research that addresses exactly what
social workers perceive to be helpful and supportive could be worthwhile given the opportunity.

48

This could be beneficial to social work practice because it may uncover some of the issues that
trigger a breakdown of split treatment relationships, and reasons why prescribing providers with
certain types of training backgrounds might be more helpful than others.
Social Workers’ Perspectives on Clients and Psychotropic Medications
Helpfulness of psychotropic medications. It is clear that the majority of social workers
in this study believe that psychotropic medications are helpful to adult clients with most forms of
mental illness, including anxiety, depression, psychosis, and bipolar affective disorder. This is
similar to the results from the 2006 Moses and Kirk and 2008 Moses studies regarding treatment
of adolescents, since the general opinion of respondents was that psychotropic medication was
more beneficial than harmful when used as treatment for mental illness in this younger
population. Despite the mostly positive views of psychotropic medications, the responses from
participants in my study and the Moses and Moses and Kirk studies are complex, since their
views on the benefits and helpfulness of medication vary greatly depending on many different
biopsychosocial factors that affect their clients.
A qualitative question from the survey from this study asked participants to specify their
level of agreement with the helpfulness of psychotropic medications depending on the type and
severity of mental illness that their clients suffered from. The majority of respondents either
agreed or strongly agreed with the helpfulness of psychotropic medications in treatment of mild
to moderate anxiety, severe anxiety, mild to moderate depression, severe depression, mood
instability and psychosis. The highest levels of agreement with the helpfulness of medications
were present for severe anxiety and depression along with psychosis. The illness categories with
the most disagreement of the helpfulness of psychotropic medications were mild to moderate
depression and mild to moderate anxiety, where a total of 13.2% of respondents either disagreed
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or strongly disagreed with the helpfulness of psychotropic medications for each of these two
categories.
Responses from qualitative questions may provide insight into the reasons why some
respondents disagree or strongly disagree with the helpfulness of psychotropic medications for
clients who struggle with less severe forms of depression and anxiety. Over half of the
respondents mentioned that the side effects of psychotropic medications are frequently an issue
in psychotherapy. Issues with dosage changes and needing multiple medication trials were also
issues brought up by clients of some of the respondents. Because of this, side effects and other
neurological/physiological issues affecting clients may have a negative influence on how social
workers perceive the overall helpfulness of medications.
Other issues from working with clients and psychotropics. Respondents in the openresponse sections of the survey mentioned some other issues that they frequently deal with in
psychotherapy with clients who are considering or already taking psychotropic medications.
First, was that clients’ perspectives regarding psychotropic medication were influenced by many
different factors in addition to information from mental health providers and actual
neurological/physiological effects. “Stigma” was frequently mentioned by respondents (25%),
which pertains to the negative cultural stigma around having a mental illness and/or having to
take medication for it.
In addition to working with clients on the role of stigma, respondents also spoke about
the difficulty of maintaining appropriate professional boundaries while still being able to help
clients (16.1%), the importance of providing psychoeducation (10.7%) and helping clients to
advocate for themselves (12.5%) regarding psychotropic medication issues. These findings
emphasize the need for clinical social worker psychotherapists to have a solid foundation of
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knowledge and ability to navigate difficult practice issues regarding the topic of psychotropic
medications. They need to be able to provide their clients with basic information about
medications since many clients might not have the ability to speak with a prescribing provider
when needed. Social workers also need to be comfortable with knowing when a client’s needs
are out of the scope of social work practice, and should be met with the help of a licensed
prescribing provider. Without this foundation, clients will be at risk of abandonment and/or
harmful interventions. Currently, social workers can obtain information on psychotropic
medication facts and issues from school, trainings, research and colleagues trained in
psychopharmacology. In order to provide their clients with the best treatment possible, it is
imperative that they actively seek out this information throughout their careers.
Study Limitations
Major limitations of this study include the sample frame and size, the survey tool was a
new and unproven instrument, and the survey only focused on the perspectives of social workers.
Since the study’s sample frame was created using snowball sampling and the frame of MBHP
and Psychology Today providers, it is not representative of the larger population. Self-selection
bias is also a likely to have affected the results because social workers had the choice to accept or
decline participation in the study. What this means is that group of social workers that declined
may have responded differently to the survey, which would have created a different set of
results. The sample size is also relatively small, also decreasing the likelihood that the results
could represent the general population. Even though the survey tool was based somewhat on
prior studies, it was still a new and unproven instrument that has not been rigorously tested to
eliminate researcher bias. A strong social work perspective also limited the perspectives that
respondents shared. Although it was by design, this study did not give prescribing practitioners
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and clients a chance to share their own perspectives firsthand. Given the opportunity, it would be
worth investigating this in the future.
Implications for Social Work Practice
One of the more disturbing findings from this study is that when treating clients with
serious mental illness, social workers communicate less with prescribing providers as the size of
their caseloads increases. What this means is that this particular vulnerable population may be
getting lower quality treatment than other groups. This issue emphasizes the need to continue
research on how socio-cultural and socio-economic factors may affect the quality of
psychotherapeutic and psychopharmacological treatment that clients are receiving. Given the
opportunity to continue this research, it will be imperative to look into how many other client
caseload demographics, such as age, socio-economic status, race, type of health care coverage,
and type of psychotherapeutic treatment being received affect the nature and quality of treatment
regarding psychopharmacological issues. When looking at caseload demographics, it will also be
necessary to take into account how non-client variables such as payers and local healthcare
statutes since these variables may influence provider communication separate from client
characteristics. It is the duty of social workers to advocate and provide for vulnerable
populations, but it is clear that very little is known about the presence or lack of discriminatory
treatment in this subject area.
Based on the results from this study and the previous studies mentioned earlier in this
chapter, it is becoming clear that there are significant barriers to communication between private
practice social workers and prescribing providers. A majority of the respondents in this study
highlighted how inaccessible prescribing providers and scheduling conflicts prevent
communication from happening as frequently as it should. Furthermore, conflicts that arise
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within professional split-treatment relationships can also prevent clients from getting the best
treatment. Gutheil and Simon (2003) suggest that social workers create pre-treatment contracts
with prescribing providers that outline each provider’s roles and responsibilities in treatment.
Such contracts may help to maintain regular communication and prevent disagreements between
providers that are detrimental to clients. This is another possible area of research where not much
is known about how often social workers engage in such arrangements and how helpful they may
be to both providers and clients. It is possible that social workers need more education on how to
build effective split-treatment relationships.
It also appears that social workers find certain types of prescribing providers to be more
helpful for clients than other types, such as psychiatric nurse practitioners and physicians’
assistants. This study did not uncover any significant findings as to why this is, but this issue is
extremely important because of how 94.5% of respondents in this study reported that more than
25% of their clients were currently taking psychotropic medications. If these statistics are similar
to the population at large, this means that almost all social worker psychotherapists in private
practice are engaged in some form of split-treatment relationships with prescribing providers. So,
if there are types of prescribing providers that make better split-treatment partners than others,
social workers could take this information into account when referring clients from medication
consultation. This information also might be useful prescribing providers who do not seem as
helpful, so that their schedules could be readjusted or their professional training could be
reshaped in order to help them focus on more effective collaborative treatment.
A third area for further research is how social worker’s preferred treatment techniques
affect how they perceive psychotropic medications and how they carry out practice in terms of
talking to clients about medications and communication with prescribing providers. This study
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did not find any relationships between treatment techniques and these topics, but this does not
mean that these relationships do not exist. There was only one quantitative question in this study
that asked participants to list the main treatment techniques that they used. An issue with this is
that respondents interpreted the meaning of this question in different ways, and were not given
the specific opportunity to explain how their treatment techniques inform their practice regarding
psychopharmacological issues. In the future, it might be fruitful to have an open-ended question
that asks them to discuss this subject. This may develop a better understanding of how
psychotherapeutic treatment techniques interface with psychopharmacological treatments.
Based on the information gathered from this study along with previous related research,
most social workers view psychotropic medications as an important tool in the treatment of
mental illness. But, it also appears that more work needs to be done to strengthen the working
relationships between social workers and psychotropic medication providers in order to provide
all mental health clients and consumers with the best care. It is the responsibility of the social
work profession to continue to push for research progress that bridges the gap between social
work and the practice of psychopharmacology.
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Maintaining Data: You must retain all data and other documents for at least three (3) years past
completion of the research activity.
In addition, these requirements may also be applicable:
Amendments: If you wish to change any aspect of the study (such as design, procedures, consent forms
or subject population), please submit these changes to the Committee.
Renewal: You are required to apply for renewal of approval every year for as long as the study is active.
Completion: You are required to notify the Chair of the Human Subjects Review Committee when your
study is completed (data collection finished). This requirement is met by completion of the thesis project
during the Third Summer.
Good luck with your research and I look forward to seeing your results.
Sincerely,

David L. Burton, M.S.W., Ph.D.
Chair, Human Subjects Review Committee
CC: Jennifer Perloff, Research Advisor
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APPENDIX B:
Informed Consent for Paper Survey
Dear Participant,
My name is Rosy Metcalfe and I am a graduate student at Smith College School for Social Work. I am
conducting a research project to learn more about social workers perspectives on psychotropic medications and
some of the issues that they encounter regarding this topic in private psychotherapy practice. This study will be
presented as a thesis and may be used in publications on this topic.

You are being asked to participate in this study if you are able to speak English and are currently a
Licensed Independent Clinical Social Worker who provides psychotherapy in part-time or full time private practice
to clients over the age of 18. If you choose to participate, I will ask you to fill out a confidential survey. The survey
will include some general questions about you and your caseload as well as questions asking you to describe your
perceptions, beliefs, and experiences regarding psychotropic medications and the prescribing providers of your
clients’ psychotropic medications, such as psychiatrists and nurse practitioners. I estimate that the amount of time
you will need to complete this survey will be 20-30 minutes.

Participation in this study may bring up feelings regarding your experiences with psychotropic medications
as a social worker and your experiences with prescribing providers. Although there will be no financial benefit to
you for your participation, my hope is that the knowledge and experiences that you share will be beneficial to the
mental health professions and the clients that we serve. You may also benefit from having the opportunity to share
your experiences and perspectives, knowing that others will hear about them.

Your confidentiality will be protected in compliance with Federal guidelines. Informed consent forms will
be removed from surveys and kept in a separate location. Please do not any identifying information in the paperbased survey.

My Smith thesis research advisor and the Smith data analyst will have access to de-identified data from the
surveys. In publications or presentations, data will be presented as a whole. Any quotations or case illustrations will
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be carefully disguised to protect the identity of participants. All data from the surveys will be kept in a secure
location for a period of three years as per Federal requirements. All data stored electronically will be protected.
Should I need these materials beyond the three-year period, they will remain secured and will be destroyed once I no
longer need them. Since this study asks you to discuss your practice as a social worker, I caution you to not identify
any of your clients.

Participation in this study is voluntary. You may withdraw from this study at any time during the process of
completing the survey and you have the right to refuse any question. If you have any questions about your rights or
any aspects of this study, do not hesitate to contact me at (personal information deleted by Laura H.
Wyman, 11/30/12) or the Chair of the Smith College School for Social Work Human Rights Subjects Review
Committee at (413) 585-7974.

BY SIGNING ON THE LINE BELOW AND WRITING THE DATE,
YOU INDICATE THAT YOU HAVE READ AND UNDERSTAND THE ABOVE
INFORMATION; THAT YOU HAVE HAD THE OPPORTUNITY TO ASK
QUESTIONS ABOUT THE STUDY, YOUR PARTICIPATION, AND YOUR
RIGHTS; AND THAT YOU AGREE TO PARTICIPATE IN THE STUDY.
Please note: When you mail me the survey using the enclosed self-addressed
stamped envelope, PLEASE INCLUDE this consent form and keep the second copy
for your records. PLEASE DO NOT include your return address on the envelope.
Signature__________________________________________
D a t e _______________
Thank you for participating in this study.
Rosy Metcalfe
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APPENDIX C:
Informed Consent for Internet Survey
Dear Participant,
My name is Rosy Metcalfe and I am a graduate student at Smith College School for Social Work. I am
conducting a research project to learn more about social workers perspectives on psychotropic medications and
some of the issues that they encounter regarding this topic in private psychotherapy practice. This study will be
presented as a thesis and may be used in publications on this topic.

You are being asked to participate in this study if you are able to speak English and are currently a
Licensed Independent Clinical Social Worker who provides psychotherapy in part-time or full time private practice
to clients over the age of 18. If you choose to participate, I will ask you to fill out a anonymous survey. The survey
will include some general questions about you and your caseload as well as questions asking you to describe your
perceptions, beliefs, and experiences regarding psychotropic medications and the prescribing providers of your
clients’ psychotropic medications, such as psychiatrists and nurse practitioners. I estimate that the amount of time
you will need to complete this survey will be 20-30 minutes.

Participation in this study may bring up feelings regarding your experiences with psychotropic medications
as a social worker and your experiences with prescribing providers. Although there will be no financial benefit to
you for your participation, my hope is that the knowledge and experiences that you share will be beneficial to the
mental health professions and the clients that we serve. You may also benefit from having the opportunity to share
your experiences and perspectives, knowing that others will hear about them.

Your confidentiality will be protected in compliance with Federal guidelines. Your IP address will remain
anonymous though the use of SurveyMonkey.Please do not include your name or any other identifying information
in the internet survey.

My Smith thesis research advisor and the Smith data analyst will have access to de-identified data from the
surveys. In publications or presentations, data will be presented as a whole. Any quotations or case illustrations will
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be carefully disguised to protect the identity of participants. All data from the surveys will be kept in a secure
location for a period of three years as per Federal requirements. All data sored electronically will be protected.
Should I need these materials beyond the three-year period, they will remain secured and will be destroyed once I no
longer need them. Since this study asks you to discuss your practice as a social worker, I caution you to not identify
any of your clients.

Participation in this study is voluntary. You may withdraw from this study at any time during the process of
completing the survey and you have the right to refuse any question. You may withdraw from this study by logging
off of the internet survey or destroying the paper-based survey. Once you have clicked “submit” on the internet
survey or mailed your paper-based survey, I will not be able to remove your survey because I will not be able to
identify your survey from the other surveys in my study.
If you have any questions about your rights or any aspects of this study, do not hesitate to contact me at (personal
information deleted by Laura H. Wyman, 11/30/12) or the Chair of the Smith College School for Social
Work Human Rights Subjects Review Committee at (413) 585-7974.
BY CHECKING "YES" THE BOX BELOW, YOU INDICATE THAT YOU HAVE READ AND UNDERSTAND
THE ABOVE INFORMATION; THAT YOU HAVE HAD THE OPPORTUNITY TO ASK QUESTIONS ABOUT
THE STUDY, YOUR PARTICIPATION, AND YOUR RIGHTS; AND THAT YOU AGREE TO PARTICIPATE
IN THE STUDY. PLEASE PRINT A COPY OF THIS PAGE FOR YOUR RECORDS.
I AGREE TO PARTICIPATE
[ ] YES
[ } NO
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APPENDIX D:
Survey
SURVEY
Thank you for participating in my survey on Social Workers in Private Practice and Psychotropic
Medications.

Screening Questions1) Are you currently a Licensed Independent Clinical Social Worker (LICSW)? [Yes/No]
2) Do you perform psychotherapy in private practice? [Yes/No]
3) Do you work with individual clients over the age of 18? [Yes/No]
*If you answered “Yes” to all three of these questions, please go on to the informed consent on the next page.
**If you answered “No” to any one of these questions, you are not eligible to participate in this study. Thank you for
your time and interest.

Note: When answering the questions on this survey, these questions are specific to your work with private practice
clients only. Do not answer these questions in terms of work that you may do with clients in other contexts.
General Information-

1) What is your age? 2) SexMale
Female
Other (Please specify):
3) RaceAlaska Native
American Indian
Asian
Black or African American
Hispanic or Latino
Multiracial
Native Hawaiian or other Pacific Islander
White
Other (please specify):
4) Years Practicing Psychotherapy, please specify:
__________

63

5) Treatment Techniques you use (select all that apply)
Coaching
Cognitive Behavioral (CBT)
Dialectical behavior Therapy
EMDR
Eclectic
Humanistic
Mindfulness Based Cognitive Therapy (MBCT)
Psychoanalytic
Psychodynamic
Other (please specify)
6) Setting of practice
Rural
Suburban
Urban
7) Total Caseload of Individual Therapy Clients in your private practice
________
8) Primary Issues of Focus with Adult Clients (select up to three starting with the most common issue in your
practice)
Addiction/Substance Abuse
Aging
Anxiety
Depression
Disability
Grieving
Personality Disorders
Psychosis
Relationships
Sexual/Gender Identity
Spirituality
Trauma
Other (please Specify)
9) Percent of your adult individual caseload who are currently taking psychotropic medications
Less than 25%
26-50%
51-75%
75-100%

Section A: Working with Providers of Psychotropic Medications
1) Types of prescribing practitioners who your clients use for their psychotropic medications. Specify how many of
each type of clinician you communicate with and frequently you had contact with each type of practitioner in the last
six months.
Psychiatrists __
More than once a week
Once a week
Once a month
Less than once a month
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Not at all
Primary Care Doctors__
More than once a week
Once a week
Once a month
Less than once a month
Not at all
Psychiatric Nurse Practitioners and Psychiatric Physician’s Assistants__
More than once a week
Once a week
Once a month
Less than once a month
Not at all
Primary Care Nurses and Physician’s Assistants__
More than once a week
Once a week
Once a month
Less than once a month
Not at all

2) With clients that are currently taking psychotropic medications for mild to moderate forms of mental illness, how
frequently to you communicate with these clients’ prescribing practitioner on average? (Examples include Mild to
moderate anxiety and/or depression, adjustment disorders, etc.)
More than once a week
Once a week
Once a month
Once every three months
Once a year
Less than once a year
3) With clients that are currently taking psychotropic medications for more serious forms of mental illness, how
frequently do you communicate with these clients’ prescribing providers? (Examples include Bipolar Affective
Disorder, Psychosis, Major Depression, etc.)
More than once a week
Once a week
Once a month
Once every three months
Once a year
Less than once a year
4) Regarding the issue of psychotropic medications, I find psychotropic medication providers to be helpful and
supportive to my clients.
A) Psychiatrists
Strongly Agree, Agree, Disagree, Strongly Disagree, Not Sure
B) Primary Care Doctors
Strongly Agree, Agree, Disagree, Strongly Disagree, Not Sure
C) Psychiatric Nurse Practitioners and Psychiatric Physician’s Assistants
Strongly Agree, Agree, Disagree, Strongly Disagree, Not Sure
D) Primary Care Nurses and Physician’s Assistants
Strongly Agree, Agree, Disagree, Strongly Disagree, Not Sure
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5) Describe the issue that you encounter most frequently when communicating with your clients prescribers of
psychotropic medications.
6) Is there anything you would like to add?
Section B: Your perspectives on psychotropic medications

1) Psychotropic medications are helpful for my clients who struggle with…
A) Mild to Moderate Anxiety
Strongly Agree, Agree, Disagree, Strongly Disagree, Not Sure
B) Severe Anxiety
Strongly Agree, Agree, Disagree, Strongly Disagree, Not Sure
C) Mild to Moderate Depression
Strongly Agree, Agree, Disagree, Strongly Disagree, Not Sure
D) Severe Depression
Strongly Agree, Agree, Disagree, Strongly Disagree, Not Sure
E) Mood Instability
Strongly Agree, Agree, Disagree, Strongly Disagree, Not Sure
F) Psychotic Symptoms
Strongly Agree, Agree, Disagree, Strongly Disagree, Not Sure
2) What issue do your clients struggle with most with regarding psychotropic medications? Please describe.
3) What dilemma do you face the most when discussing psychotropic medications with your clients? Please
describe.
4) Is there anything you would like to add?
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APPENDIX E:
Recruitment Mailing
Dear ___________ ,
I am writing to ask for your participation in my study on how social workers in private practice view the role of
psychotropic medications in treatment and handle psychopharmacological issues in practice. In my study, I am
hoping to collect information from a diverse sample of Licensed Independent Clinical Social Workers in either parttime or full-time private practice to gather a better understanding of how social workers in private practice perceive
psychotropic medications, how they handle issues regarding medication with their clients and how the communicate
with prescribing practitioners. Participants must be able to speak English, be currently licensed independent clinical
social workers and be providing psychotherapy in private practice to adult clients.
For the study, participants will be asked to fill out a confidential survey. If you are interested, you can access the
survey anonymously at https://www.surveymonkey.com/s/6X8MY6K if you have an internet connection or you can
call me at (personal information deleted by Laura H. Wyman, 11/30/12) for a printed version which I will
mail to with a self-addressed/stamped envelope. If you call me for the printed version, you will not have to give their
name, only your mailing address. In addition, please forward this email or my phone number along to any of your
own contacts who might be interested in participating in the study or aiding me in the recruitment process. Thank
you very much for your support. If you are interested in hearing about my findings when I have completed my
study, please contact me. Also, if you have any questions, do not hesitate to get in touch with me.
Sincerely,

Rosy Lea Metcalfe
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APPENDIX F:
Recruitment Telephone Greeting
My name is Rosy Metcalfe. I am currently a master’s degree student at Smith College School for Social
Work. I am contacting to ask for your participation in my study on how social workers in private practice view the
role of psychotropic medications in treatment and handle psychopharmacological issues in practice. In my study, I
am hoping to collect information from a diverse sample of Licensed Independent Clinical Social Workers in parttime or full-time private practice to gather a better understanding of how you perceive psychotropic medications,
how you handle issues regarding medication with their clients and how you communicate with prescribing
practitioners. Participants must be currently licensed independent clinical social workers and be providing
psychotherapy in private practice to adult clients. For the study, you will be asked to fill out a confidential survey. If
you are interested, I can email you the link to my survey website, or I you prefer I not to be emailed, the address for
my anonymous survey is https://www.surveymonkey.com/s/6X8MY6K.
I can also mail you a printed version, which I will mail to with a self-addressed/stamped envelope. If you
call me for the printed version, you will not have to give their name, only your mailing address. In addition, please
forward this survey website or my phone number along to any of your own contacts who might be interested in
participating in the study or aiding me in the recruitment process.
Thank you very much for your support. If you are interested in hearing about my findings when I have
completed my study, please contact me. Also, if you have any questions, do not hesitate to get in touch with me.
Thank for your time.
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